Chaperon Newsletter No. 05/2022

Dear Chaperon subscribers,

we have new information for you from the Chaperon project!

NEW PAPER:Genome-wide meta-analysis of monoclonal gammopathy of undetermined significance (MGUS) identifies risk loci impacting IRF-6

Monoclonal gammopathy of undetermined significance (MGUS) is a benign plasma cell disorder, common in the Western population (3–5% ≥50 years) and characterized by an asymptomatic clonal plasma cell expansion. MGUS progresses to multiple myeloma (MM) at a rate of 1% per year but can also progress to light chain amyloidosis (AL amyloidosis), Waldenström macroglobulinemia, and lymphoma. A detailed overview has been recently published in an article co-authored by our ERA Chair holder, prof. Hemminki.

Cancer research reigned over Javorná for the eleventh time

From May 20th to 22nd, another installment of the regular scientific meeting took place, bringing together collaborating research teams of not only the Faculty of Medicine in Pilsen but also experts from the Institute of Experimental Medicine of the Czech Academy of Sciences and from the National Institute of Public Health. More information here…


Picture of the month

Introducing the winners and participants of the Nerd Art Prize, we are glad to present another picture of the month. In May is it a picture by Kamal Mezian, MD, PhD.Department of Rehabilitation Medicine, First Faculty of Medicine Charles University. See more here..


Invitation: Commercialization of Applied Research Results

The Chaperon invites you to participate in our seminar called “Commercialization of Applied Research Results”, which was prepared in cooperation with the University of West Bohemia in Pilsen. More information here..


ERA Chair Position for Excellent Research in Oncology

A project funded from the European Union's Horizon 2020 research and innovation programme under grant agreement No 856620.



Charles University
Faculty of Medicine in Pilsen
Biomedical Center

alej Svobody 1655/76
323 00 Plzeň – Severní Předměstí

T: +420 377 593 810
E: This email address is being protected from spambots. You need JavaScript enabled to view it.


Log in to your account or Create an account